BI Asset Management Fondsmaeglerselskab A S Reduces Position in The Clorox Company $CLX

BI Asset Management Fondsmaeglerselskab A S trimmed its holdings in The Clorox Company (NYSE:CLX) by 41.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 53,665 shares of the company’s stock after selling 37,527 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Clorox were worth $5,411,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Ipsen Advisor Group LLC purchased a new stake in shares of Clorox in the 4th quarter worth $409,000. Pinebridge Investments LLC bought a new position in shares of Clorox during the fourth quarter valued at approximately $13,587,000. Nuance Investments LLC increased its holdings in Clorox by 13.2% during the fourth quarter. Nuance Investments LLC now owns 786,789 shares of the company’s stock valued at $79,332,000 after buying an additional 91,972 shares during the period. Victrix Investment Advisors bought a new position in Clorox in the fourth quarter worth approximately $364,000. Finally, Vise Technologies Inc. raised its stake in Clorox by 40.7% in the fourth quarter. Vise Technologies Inc. now owns 3,156 shares of the company’s stock worth $318,000 after buying an additional 913 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Activity at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on CLX. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Royal Bank Of Canada cut their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Jefferies Financial Group reduced their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Morgan Stanley decreased their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Stock Performance

Shares of CLX opened at $94.07 on Monday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a 50-day moving average of $96.95 and a two-hundred day moving average of $105.34. The stock has a market cap of $11.37 billion, a P/E ratio of 15.27, a P/E/G ratio of 0.49 and a beta of 0.56. The Clorox Company has a one year low of $84.70 and a one year high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm posted $1.45 EPS. Clorox’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.